Skip to main content

Table 2 Risk factors for intravesical recurrence after a second TUR

From: Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer

Variables

Univariate

Multivariate

HR (95 % CI)

p-value

HR (95 % CI)

p-value

Age (≥70)

0.97

(0.85–1.11)

0.68

0.98

(0.79–1.23)

0.87

Gender (female)

1.04

(0.35–3.07)

0.95

1.06

(0.33–3.44)

0.92

Urine cytology before the initial TUR (suspicious positive and positive)

1.52

(0.44–5.22)

0.50

1.77

(0.48–6.54)

0.39

Tumor size (≥3 cm)

1.95

(0.84–4.53)

0.12

2.73

(1.07–7.00)

0.03*

Tumor number (multiple)

0.62

(0.27–1.45)

0.27

0.94

(0.37–2.38)

0.89

Concomitant CIS (existence)

1.23

(0.29–5.25)

0.78

3.21

(0.62–16.67)

0.17

BCG induction instillation (without)

0.28

(0.12–0.67)

<0.01**

0.20

(0.07–0.57)

<0.01**

  1. *p<0.05, **p<0.01 indicate significant differences